In January-May 2025, retail sales of veterinary drugs in Russia amounted to 21.2 billion rubles (in retail prices), 14.4% up y-o-y in rubles. However, according to the analytical company RNC Pharma, in natural units (minimum marketed doses, MMD) the market was down 2.9%, at 40.4 billion units. Analysts report that the main growth was provided by the online sales channel, where volumes increased by 56% in monetary terms and 55% in natural units, while offline sales were only 2.5% up in rubles and 9.1% down in MMD.
Experts added that seasonal activity in the market in 2025 began earlier than usual, reaching its peak in March and April. However, by May, demand had noticeably decreased, with sales amounting to 8.9 million minimum units and worth 4.6 billion rubles, a decrease of 4.5% in natural units and an increase of 14.7% in monetary terms compared to May 2024. The long-term dynamics in April turned out to be weaker than expected due to the earlier start of the season.
Experts also noted that in the first 5 months of the year, the range of the retail segment of the veterinary market decreased: the total number of INNs went down by one position (to 762 units) over the year, while the list of trademarks became 15 items shorter.
New products have appreared on the market. Analysts highlighted Ticksflee (carbamoyl benzamide phenyl isoxazoline) manufactured by the Russian company Vetpharmstandart. Launched in January 2025, it already ranks fourth among the best selling drugs. This insecticide is a generic version of MSD’s Bravecto, which is also showing sales growth, 49% up in natural units and 17% up in monetary terms, due to lower retail prices.
The absolute leader in terms of the growth rate in the top 10 on the veterinary drug market is the Multican line of combined vaccines (Vetbiokhim, Russia). It has demonstrated a twofold increase in monetary terms. Among the top ten, experts noted 82-fold growth rates for Vemelcam (Nita-Pharm, Russia). Milbemax (+6%) and Bars (+9%) recorded the lowest growth among the market leaders, with a decrease in natural units.
Earlier, RNC Pharma reported that prices for veterinary drugs in the Russian retail market, including online sales, increased by 17.7% in the first quarter of 2025 compared to the same period last year. In March of this year, the rise in prices for domestic medicines for animals outpaced the increase for imported products.
